ATA307580A - Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditions- salzen - Google Patents
Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditions- salzenInfo
- Publication number
- ATA307580A ATA307580A AT803075A AT307580A ATA307580A AT A307580 A ATA307580 A AT A307580A AT 803075 A AT803075 A AT 803075A AT 307580 A AT307580 A AT 307580A AT A307580 A ATA307580 A AT A307580A
- Authority
- AT
- Austria
- Prior art keywords
- ureanilides
- hydroxypropoxy
- furan
- alkylamino
- carbons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/70—Nitro radicals
- C07D307/71—Nitro radicals attached in position 5
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2923817A DE2923817C2 (de) | 1979-06-12 | 1979-06-12 | (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA307580A true ATA307580A (de) | 1984-04-15 |
| AT376428B AT376428B (de) | 1984-11-26 |
Family
ID=6073081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0307580A AT376428B (de) | 1979-06-12 | 1980-06-11 | Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditionssalzen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4269855A (de) |
| JP (1) | JPS562977A (de) |
| AT (1) | AT376428B (de) |
| AU (1) | AU535945B2 (de) |
| BE (1) | BE883766A (de) |
| CA (1) | CA1146953A (de) |
| CH (1) | CH643250A5 (de) |
| DE (1) | DE2923817C2 (de) |
| FR (1) | FR2458548A1 (de) |
| GB (1) | GB2051796B (de) |
| IT (1) | IT1131822B (de) |
| NL (1) | NL8003385A (de) |
| SE (1) | SE448377B (de) |
| ZA (1) | ZA803466B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510573B1 (fr) * | 1981-07-29 | 1985-07-26 | Carpibem | (2-substitue 4-(thienyl acetamido) phenoxy) hydroxy propylamines, leur preparation, leur utilisation en therapeutique, et nouveaux intermediaires |
| FR2530245A1 (fr) * | 1982-07-16 | 1984-01-20 | Carpibem | Nouveaux 1-(2-carbalkoxy 4-(thienyl-alkylamido)phenoxy) 3-amino 2-propanols, leur preparation et leurs applications en therapeutique |
| IE56108B1 (en) * | 1982-07-16 | 1991-04-24 | Carpibem | 1-(2-carbalkoxy-4-(thienylcarboxamido)phenoxy)-3-amino 2-propanols,their preparation and applications thereof in therapeutics |
| FR2555179B1 (fr) * | 1983-11-21 | 1986-11-21 | Carpibem | Nouveaux (carbethoxy-2 furyl- ou benzofuryl-carboxamido-4 phenoxy)-1 amino-3 propanols-2 : leurs preparations et leurs applications en therapeutique |
| US6300368B1 (en) * | 1998-06-30 | 2001-10-09 | Mitsui Chemicals, Inc. | Anilide derivatives and antiarrhythmic agents containing the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1543689A (fr) * | 1966-11-03 | 1968-10-25 | Ici Ltd | Procédé de fabrication de nouvelles alcanolamines et de leurs dérivés |
| US3959481A (en) * | 1969-02-13 | 1976-05-25 | Uniroyal | Method of protecting plants from fungal diseases using furan-3-carboxamide derivatives |
| JPS5749552B2 (de) * | 1972-06-07 | 1982-10-22 | ||
| GB1531718A (en) * | 1974-11-20 | 1978-11-08 | Pharmacia As | Phenylethanolamines |
| DE2800504A1 (de) * | 1978-01-05 | 1979-07-12 | Consortium Elektrochem Ind | Verfahren zur herstellung von furancarbonsaeureanilid |
-
1979
- 1979-06-12 DE DE2923817A patent/DE2923817C2/de not_active Expired
-
1980
- 1980-04-14 CH CH285380A patent/CH643250A5/de not_active IP Right Cessation
- 1980-04-16 CA CA000350002A patent/CA1146953A/en not_active Expired
- 1980-05-29 GB GB8017550A patent/GB2051796B/en not_active Expired
- 1980-06-03 US US06/155,953 patent/US4269855A/en not_active Expired - Lifetime
- 1980-06-10 FR FR8012839A patent/FR2458548A1/fr active Granted
- 1980-06-11 ZA ZA00803466A patent/ZA803466B/xx unknown
- 1980-06-11 SE SE8004351A patent/SE448377B/sv not_active IP Right Cessation
- 1980-06-11 IT IT22724/80A patent/IT1131822B/it active
- 1980-06-11 AT AT0307580A patent/AT376428B/de not_active IP Right Cessation
- 1980-06-11 AU AU59212/80A patent/AU535945B2/en not_active Ceased
- 1980-06-11 JP JP7790780A patent/JPS562977A/ja active Pending
- 1980-06-11 NL NL8003385A patent/NL8003385A/nl not_active Application Discontinuation
- 1980-06-11 BE BE0/200995A patent/BE883766A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1146953A (en) | 1983-05-24 |
| NL8003385A (nl) | 1980-12-16 |
| FR2458548B1 (de) | 1983-08-05 |
| SE8004351L (sv) | 1980-12-13 |
| AT376428B (de) | 1984-11-26 |
| CH643250A5 (de) | 1984-05-30 |
| IT1131822B (it) | 1986-06-25 |
| ZA803466B (en) | 1981-06-24 |
| AU535945B2 (en) | 1984-04-12 |
| GB2051796A (en) | 1981-01-21 |
| SE448377B (sv) | 1987-02-16 |
| DE2923817B1 (de) | 1980-08-14 |
| JPS562977A (en) | 1981-01-13 |
| FR2458548A1 (fr) | 1981-01-02 |
| US4269855A (en) | 1981-05-26 |
| AU5921280A (en) | 1980-12-18 |
| BE883766A (fr) | 1980-10-01 |
| DE2923817C2 (de) | 1981-07-09 |
| GB2051796B (en) | 1983-04-27 |
| IT8022724A0 (it) | 1980-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT373887B (de) | Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen | |
| AT361937B (de) | Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen | |
| AT366662B (de) | Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen | |
| AT361480B (de) | Verfahren zur herstellung von neuen amino- alkoxyphenyl-derivaten und deren physiologisch vertraeglichen saeureadditionssalzen | |
| AT369731B (de) | Verfahren zur herstellung von neuen 4-pyridon-3-carbonsaeurederivaten und deren salzen | |
| AT363923B (de) | Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen | |
| ATA272382A (de) | Verfahren zur herstellung von neuen 3,7-diazabicyclo/3,3,1/ nonanderivaten, deren stereoisomren und physiologisch vertraeglichen saeureadditionssalzen | |
| AT376428B (de) | Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditionssalzen | |
| AT371438B (de) | Verfahren zur herstellung von neuen n-alkenylmoranolinderivaten und ihrer saeureadditionssalze | |
| AT359474B (de) | Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen | |
| AT377767B (de) | Verfahren zur herstellung von neuen 4-aza-17subst.-5alpha-androstan-3-onen und deren pharmazeutisch verwendbaren salzen | |
| AT363463B (de) | Verfahren zur herstellung von neuen 5-sulfamoyl-orthanilsaeuren und deren physiologisch vertraeglichen salzen | |
| AT372081B (de) | Verfahren zur herstellung von neuen substituierten n-iminomethylpiperidinen und von deren saeureadditionssalzen | |
| AT360033B (de) | Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen | |
| ATA238683A (de) | Verfahren zur herstellung von neuen eburnan-oxim-aether-derivaten und von deren saeureadditionssalzen | |
| AT360010B (de) | Verfahren zur herstellung von neuen azabicyclo- alkanen und deren physiologisch vertraeglichen saeureadditionssalzen | |
| ATA398678A (de) | Verfahren zur herstellung von neuen 4- acetamidophenyl-alpha-(2-methyl-ind(en/ol)- -3-yl)-acetaten und deren saeureadditionssalzen | |
| ATA238583A (de) | Verfahren zur herstellung von neuen eburnanderivaten und deren saeureadditionssalzen | |
| AT369740B (de) | Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen | |
| AT376438B (de) | Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen | |
| ATA144581A (de) | Verfahren zur herstellung von neuen phenylessig- saeure-derivaten und deren salzen | |
| ATA614979A (de) | Verfahren zur herstellung von neuen amino- alkoxyphenyl-derivaten und deren physiologisch vertraeglichen saeureadditionssalzen | |
| AT365559B (de) | Verfahren zur herstellung von aminopropandiolmono-aethern und deren saeureadditionssalzen | |
| ATA148580A (de) | Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen | |
| ATA333583A (de) | Verfahren zur herstellung von neuen indolizinderivaten und deren pharmazeutisch zulaessigen saeureadditionssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |